Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.300
+0.170 (7.98%)
Oct 19, 2026, 1:20 PM EDT - Market open
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $217.75 million as of October 19, 2026. It is the 20,716th most valuable company in the world and the 3,561st biggest in the United States. Its market cap has increased by 102.59% in one year.
Market Cap
217.75M
Enterprise Value
80.83M
1-Year Change
102.59%
Global Rank
Country Rank
#3,561 United States
Category
ChartMarket Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $217.75M, a decrease of -62.93%. That is a compound annual growth rate of -14.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 217.75M | 149.10% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Greenwich LifeSciences | 213.57M |
| Keros Therapeutics | 211.36M |
| Protalix BioTherapeutics | 211.10M |
| Sol-Gel Technologies | 210.35M |
| Larimar Therapeutics | 207.20M |
| MacroGenics | 207.03M |
| Alector | 205.45M |
| Pyxis Oncology | 200.69M |